Delivery Order SPE2DB22D2206-SPE2DB25FJQ97
- Not listed
- The Defense Logistics Agency awarded a $17,940.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product on August 25, 2025, with an ultimate completion date of September 16, 2025. This is a non-set-aside competitive award with performance at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $478,416.80 to AmerisourceBergen Drug Corp for Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical products. This firm fixed price delivery order, awarded on September 2, 2025, represents a non-competitive, competitively awarded procurement with an ultimate completion date of September 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a $35,881.26 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product, with performance completion targeted for September 9, 2025. This non-competitive delivery order employs firm fixed price pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This firm fixed-price delivery order, valued at $11,960.42, represents a non-competitive, non-set-aside procurement and is scheduled for completion by August 4, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $59,802.10 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Darzalex FasPro 1,800mg-30,000 15ml pharmaceutical product. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 11, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating the award was made through open...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This non-set-aside, competitively awarded delivery order carries a ceiling value of $95,683.36 under a firm fixed price contract type, with an ultimate completion date of August 29, 2025. The award was made on August 8, 2025, and the place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical products, with a contract ceiling value of $478,416.80. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for completion by October 6, 2025, and will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $59,802.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for supply of Darzalex Faspro 1,800mg-30,000 15ml on September 16, 2025, with completion targeted for October 7, 2025. This non-competitive delivery order represents a pharmaceutical supply requirement for military healthcare systems and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating the...
- The Defense Logistics Agency awarded a delivery order valued at $71,762.52 to AmerisourceBergen Drug Corp for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This is a firm fixed price, non-competitive delivery order with a completion date of July 29, 2025, issued on July 8, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and operations as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $35,881.26 to AmerisourceBergen Drug Corp for Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical products. This firm fixed price delivery order, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, represents a competitive award with no set-aside designation. The products will be supplied to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters and primary...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJQ97Delivery Order
The Defense Logistics Agency awarded a $59,802.10 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, was competitively awarded without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime indefinite delivery contract extending through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for the Defense Logistics Agency's medical supply chain. The company's extensive portfolio of federal contract awards demonstrates its capability to deliver a wide spectrum of pharmaceutical products including specialty medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Darzalex Faspro—a specialty pharmaceutical product used in hematologic malignancy treatment—exemplifies the company's role in supporting military and federal healthcare systems through competitively awarded contracts with firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $59.8k | 8/26/25 |